Astrazeneca falls after reporting loss in Q3

Astrazeneca Pharma India, an integrated biopharmaceutical company, fell on Thursday after it has posted a net loss of Rs 176.95 million for the quarter ended Dec. 31, 2012 as compared to net profit of Rs 149.37 million for the same period in the previous year.

Net sales has decreased 31.65% to Rs 1.05 billion for the quarter ended Dec 31, 2012 from Rs 1.54 billion for the same period in the previous year. Shares ofthe companyIndia are trading at Rs 1,302, down Rs 21.65, or 1.64% at the Bombay Stock Exchange (BSE) on Thursday at 9:52 a.m.The scrip has touched an intra-day high of Rs 1,320 and low of Rs 1,291. The total volume of shares traded at the BSE is 1,345.In the earlier session, the shares declined 0.2%, or Rs 2.64, at Rs 1,323.65. Currently, the stock is trading at all time 52-week low, which is below 50.85% over the 52-week high of Rs 2,649.00.

Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 1,346.50 (22.85) (1.70) 1 Month 1,404.90 (81.25) (5.78) 3 Months 1,495.20 (171.55) (11.47) 6 Months 1,626.55 (302.90) (18.62) 1 Year 1,689.45 (365.80) (21.65) Note: Based on previous day closing price.